Osimertinib

#162 - Sarah Hallberg, D.O., M.S.: Treating metabolic disease, & a personal journey through cancer

Peter Attia MD

A newer generation TKI that Dr. Hallberg was switched to after the initial TKI failed, used to treat her EGFR-mutated lung cancer.